Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00116896
Status:
COMPLETED
Last Update Posted:
2009-01-21
First Post:
2005-06-30
Brief Title:
Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors
Sponsor:
OSI Pharmaceuticals
Organization:
OSI Pharmaceuticals
Study Overview
Official Title:
Phase I Study of OSI-7904L in Combination With Cisplatin in Patients With Advanced Solid Tumors
Status:
COMPLETED
Status Verified Date:
2003-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a Phase I open-label dose escalation study of the combination of cisplatin and OSI-7904L given on Day 1 every 21 days in patient who have advanced solid tumors
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None